bioAffinity Technologies (BIAF) shares fell 13% in Wednesday trading after it said it has priced a public offering of 4 million shares of common stock, or pre-funded warrants in lieu thereof, at $0.80 per share for gross proceeds of $3.2 million.
The biotech firm said it expects the offering to close Thursday.
Investors may instead purchase pre-funded warrants at $0.793 each, with each warrant exercisable for one share of common stock.
Price: 0.83, Change: -0.12, Percent Change: -12.22
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments